Media >
Neuroscience
-
Neurotech | Science CEO Max Hodak Joins DOC 2026 Faculty
Science CEO Max Hodak joins the DOC 2026 Faculty. A brain-computer interface pioneer, he created PRIMA, the first treatment to restore vision in advanced AMD.
-
Neurotech | Amy Kruse, Ph.D., Joins DOC 2026 Faculty
Satori Neuro CIO and neuroscientist Amy Kruse, Ph.D., joins DOC 2026 Faculty, bringing DARPA roots and deep expertise in precision neuroscience, neurotech, and brain-computer interfaces.
-
DOC 2026 Program Is Live!
The DOC 2026 program is live. Join 300 leaders in longevity, neuroscience, medical AI, and women’s health this October in Sonoma for the summit.
-
DOC Salon: All Science, No Bullsh*t
A private dinner brought together physicians, AI pioneers, and research funders to discuss longevity science, AI in clinical care, and the future of medicine.
-
Longevity Science | Edward Chang, M.D. Joins DOC 2026 Faculty
The far-reaching work of Neurosurgeon and scientist Edward Chang, M.D., includes research into the neural systems that control emotions, learning, movement, and speech.
-
Dr. Claire Clelland: From Genetic Mutations to Targeted Cures
Dr. Claire Clelland, UCSF’s John D French Alzheimer’s Foundation Endowed Chair, believes biologic therapies could reach clinical trials faster by testing them with human tissue.
-
DOC 2025 Video: Brain Disease Breakthroughs
Dr. Eric Verdin spoke with Dr. Li Gan, Dr. Claire Clelland, and Dr. David Jones on neurodegenerative disease discoveries and novel therapies at DOC 2025.
-
Longevity Science | Nir Barzilai, M.D. Joins DOC 2026 Faculty
As Albert Einstein College of Medicine’s Professor of Medicine and Genetics, geroscientist Nir Barzilai, M.D. has shifted how aging and diseases are viewed and treated.
-
Dr. Li Gan: The Role of Tau and Inflammation in Alzheimer’s Research
Dr. Li Gan of Weill Cornell Medicine is shifting Alzheimer’s research beyond amyloid, focusing on tau protein and inflammation as key drivers of cognitive decline.
-
Dr. David Jones: Democratizing Access to Specialized Brain Care
Dr. David Jones, Director of Mayo Clinic’s Neurology Artificial Intelligence Program, developed StateViewer, an AI tool that diagnoses 14 types of dementia using brain scans.
-
DOC 2026 Welcomes ARPA-H Director Dr. Alicia Jackson as Keynote Speaker
A founder, CEO, and researcher, ARPA-H Director Dr. Alicia Jackson brings firsthand experience navigating the challenges of translating scientific breakthroughs into practical applications.
-
Dr. George Slavich: How Ten Minutes of Negativity Can Harm The Body
Teaching people how to develop psychosocial resilience may mitigate acute social pain and reduce stressors to improve overall health, says UCLA’ s Dr. George Slavich.
-
DOC 2025 Video: The Science of Sex, Stress, and Longevity
Dr. Elissa Epel, Dr. Britney Blair, and Dr. George Slavich say roadmaps for a long, happy life involve sex, stress reduction, and a mindfulness practice.
-
Clinical Breakthroughs and AI | David T. Jones, M.D. Joins DOC 2025 Faculty
David T. Jones, M.D., the Director of the Mayo Clinic Neurology Artificial Intelligence Program, has expanded the therapeutics and clinical care of neurodegenerative disorders.
-
Clinical Breakthroughs | Li Gan, Ph.D. Joins DOC 2025 Faculty
Weill Cornell Medicine Neuroscientist Li Gan, Ph.D., is a leading researcher in Alzheimer’s and fundamentally shifting the exploration of treatments for neurodegenerative diseases.
-
Clinical Breakthroughs | Claire Clelland, M.D., Ph.D., M.Phil Joins DOC 2025 Faculty
Neurologist Claire Clelland, M.D., Ph.D., researches neurodegenerative diseases at UCSF, where she holds the John D. French Alzheimer’s Foundation Endowed Chair.
-
The Neuroscientist’s Digital Prescription
Over half a billion people suffer from what Dr. Adam Gazzaley, neuroscientist at University of California at San Francisco, calls “debilitating effects of impaired cognition.”
-
Clinical Breakthroughs | Tony Masri, M.D. Joins DOC 2025 Faculty
Neurologist and board-certified sleep specialist Tony Masri, M.D. has dedicated his research and practice to sleep and its effect on overall health.
-
The DOC 2025 Program Is Live!
We’re excited to release the DOC 2025 Program, including the Great Debate on AI and Medicine, talks on longevity medicine, women’s health, proteomics and more.
-
A New Model For Neuro Therapeutics – Arjun JJ Desai, M.D. at DOC 2024
Dr. Arjun (JJ) Desai discusses the novel use of focused ultrasound to break the brain-blood barrier for drug delivery, among several other clinical breakthroughs.
-
Beyond Touch, Sight, and Hearing: Creating New Senses – David Eagleman, Ph.D. at DOC 2024
Neuroscientist David Eagleman presents his groundbreaking work training the brain to perceive new forms of sensory inputs at DOC 2024.
-
The DOCUMENT Fourth Edition
A central feature of the DOC experience, the Living Room Lab will spotlight a highly curated set of science-driven, early-stage healthcare companies.
Loading posts…
No more posts
Recommended